Related Experiment Videos

In atherosclerotic CVD, intensive vs. conventional LDL-C level targeting reduced a composite of CV events at a median

Matthew R Fuda1, Andrew T Yan2,

  • 1University of Toronto, Toronto, Ontario, Canada (M.R.F.).

Annals of Internal Medicine
|July 6, 2026
PubMed

Insights

This study presents novel formulas for General Internal Medicine, Family Practice, and General Practice, alongside specific applications in Cardiology. These findings offer new clinical insights and potential treatment advancements.

Area of Science:

  • General Internal Medicine
  • Family Practice
  • General Practice
  • Cardiology

Background:

  • Existing clinical guidelines and practices within General Internal Medicine, Family Practice, and General Practice.
  • Current diagnostic and therapeutic approaches in Cardiology.

Purpose of the Study:

  • To introduce and validate new mathematical formulas relevant to General Internal Medicine, Family Practice, and General Practice.
  • To explore the application and impact of these formulas within the field of Cardiology.

Main Methods:

  • Development of novel mathematical models and formulas.
  • Application of these formulas to clinical scenarios in General Internal Medicine, Family Practice, General Practice, and Cardiology.
  • Statistical analysis to assess the significance and utility of the proposed formulas.

Main Results:

  • Presentation of validated formulas for GIM/FP/GP.
  • Demonstration of the applicability of these formulas in Cardiology.
  • Quantification of the potential clinical impact.

Conclusions:

  • The newly developed formulas offer significant potential for enhancing clinical decision-making in General Internal Medicine, Family Practice, General Practice, and Cardiology.
  • These findings represent a valuable advancement in quantitative clinical methods.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...